Biotech

All Articles

Lykos will definitely talk to FDA to reconsider its choice observing denial of MDMA treatment for post-traumatic stress disorder

.Complying with an inadequate revealing for Lykos Therapies' MDMA prospect for post-traumatic stress...

AN 2 halves census, stops stage 3 test after data let down

.AN2 Therapies is actually rethinking its company in action to lackluster midphase data, pledging to...

Merck pays $700M for bispecific, snooping autoimmune opening and also chance to challenge Amgen in cancer cells

.Merck &amp Co. is paying $700 million ahead of time to challenge Amgen in a blood cancer cells mark...

Gilead spends J&ampJ $320M to leave licensing offer for seladelpar

.Along With Gilead Sciences about to an FDA selection for its liver illness medication seladelpar, t...

' All palms on deck' at Lilly as peers target being overweight market

.CEO David Ricks can see the firms setting up camping tents at basecamp behind Eli Lilly in a try to...

Entero giving up workers, vacating office as well as stopping R&ampD

.Bed Liquidators has actually switched Entero Therapeutics white colored as a sheet. The collector o...

Exelixis falls ADC after deciding it is actually no suit for Tivdak

.Exelixis is actually surrendering on its cells aspect (TF)- targeting antibody-drug conjugate after...

Relay loses interest in SHP2 prevention after Genentech leaves

.Three full weeks after Roche's Genentech device bowed out an SHP2 inhibitor contract, Relay Rehab h...

Stoke's Dravet syndrome med launched of partial clinical grip

.Stoke Therapies' Dravet disorder medication has been freed from a partial grip, removing the means ...

Fierce Biotech's Gabrielle Masson provides Intense 15 at NYSE

.Strong Biotech Affiliate Publisher Gabrielle Masson provided the 2024 class of Brutal 15 champions ...